Relevate Health Group Funding, Investors & Competitors

Relevate Health Group has raised $140M across 3 funding rounds, most recently a $56M undisclosed-stage round in April 2022.

Last Relevate Health Group funding round

$56M

Undisclosed stage · Apr 2022

Cumulative funding Relevate Health Group raised

$140M

across 3 funding rounds

Relevate Health Group Overview

About Relevate Health Group

Relevate Health Group is a Yardley-headquartered firm specializing in healthcare audience targeting for hospitals, health systems, and life sciences companies. Its patented platform analyzes local market data from electronic health records and claims to deliver precise patient outreach. Serving over 200 U.S. providers including Penn Medicine and AstraZeneca, Relevate has operated exclusively in healthcare since 2004 with a focus on growth strategies.


Founded

2015

HQ

United StatesCincinnati, OH

Status

Privately held

Customer focus

B2B

Revenue model

Services, Subscription

Relevate Health Group Funding History

Relevate Health Group has raised a total of $140M across 3 funding rounds.

Relevate Health Group's first fundraising round was a $18M undisclosed-stage round in December 2020. The most recent completed round was a $56M undisclosed-stage round in April 2022.

Relevate Health Group funding rounds

Relevate Health Group funding rounds
DateStageRaisedDeal Summary
Apr 2022Undisclosed stage$56MRelevate Health is a healthcare marketing and communications agency that specializes in physician (HCP) engagement and direct-to-consumer (DTC) promotional work for pharmaceutical companies. The company provides services including HCP engagement products, patient education materials through MyDoc, and omnichannel strategy alignment through its Treatment Perspectives suite. Relevate Health received an equity investment from Denver-based private equity firm Mountaingate Capital in December 2020. Following this investment, the company pursued an active acquisition strategy, acquiring HCP engagement product maker Axon Communications in late 2021 and HCP recruitment network ConneXion360 in April 2022. These acquisitions drove significant growth, with Relevate's revenue surging 71% in 2022 to $69.4 million from $40.6 million in 2021. The company expanded its client roster to include major pharmaceutical companies such as Incyte, Amarin, Alkermes, Fresenius Kabi, Akebia Therapeutics, Novo Nordisk, Janssen, and Amgen. Headcount grew from 170 full-time employees at the start of 2022 to 199 by year-end, and the company added CFO Louis-Philippe Cavallo. As of March 2026, Mountaingate Capital is planning to bring Relevate Health to market for sale.
Jan 2022Undisclosed stage$66MRelevate Health Group is a Cincinnati-based data-driven healthcare marketing agency specializing in omnichannel strategies for pharmaceutical, biotech, and medical device clients, including HCP engagement, patient education tools like MyDoc, and the Treatment Perspectives suite. Backed by private equity firm Mountaingate Capital since a 2020 acquisition, Relevate pursued a buy-and-build strategy with add-on acquisitions such as Arteric in November 2020, Axon Communications at the end of 2021 (later subject to a $80.1 million unwind lawsuit), and ConneXion360 in April 2022 to expand HCP recruitment, digital products, video production, and access to health systems. No specific VC funding round is detailed around July 2022; activities centered on these PE-backed acquisitions rather than traditional equity financings. In 2022, revenue grew 71% to $69.4 million from $40.6 million in 2021, driven by integrations from acquisitions and new client engagements with Incyte, Amarin, Alkermes, Fresenius Kabi, Akebia Therapeutics, alongside existing partners like Novo Nordisk, Janssen, and Amgen. Headcount rose from 170 to 199 full-time employees. Growth continued into 2023 with revenue reaching $76.6 million (or $64.0 million per another report), supporting 29 product launches, and leveraging the ELE data platform informed by nine years of HCP behavioral data. As of early 2026, Mountaingate plans to sell Relevate.
Dec 2020Undisclosed stage$18MRelevate Health Group is a Cincinnati-based data-driven healthcare marketing agency. Mountaingate Capital acquired Relevate Health Group on November 20, 2020, as a platform investment in a buyout transaction. Immediately following the acquisition, Relevate acquired Arteric, a digital-native agency specializing in machine learning-based multichannel programs, to form a combined data- and ML-driven healthcare marketing platform. Relevate Health's latest funding round was a Line of Credit on December 22, 2020, led by Monroe Capital. Mountaingate Capital, a Denver-based middle-market buy-and-build private equity firm, backs Relevate's growth strategy through add-on acquisitions.

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Relevate Health Group

Relevate Health Group has acquired 3 companies to date.

Last acquisition by Relevate Health Group was on April 25th 2022. Relevate Health Group acquired ConneXion 360 for undisclosed valuation.


Latest Acquisitions by Relevate Health Group

ConneXion 360
Axon Communications
Arteric
Description
ConneXion 360 is a healthcare-focused media network that delivers live streaming, webcasting, digital signage, and video production services to hospitals and clinics. Mountain View-based, it equips over 200 facilities with on-demand broadcasting tools for patient education, staff training, and physician communications. The platform integrates with electronic health records and supports multilingual content delivery across waiting rooms, patient rooms, and mobile devices in the United States.
Axon Communications is a Yardley-based agency delivering digital marketing, market access, and patient engagement solutions for pharmaceutical, biotech, and medtech clients. The firm manages HCP portals, omnichannel campaigns, and compliance-reviewed content for brands in oncology and rare diseases.
Arteric is a Metuchen-headquartered interactive agency specializing in responsive websites, mobile applications, and digital solutions for healthcare organizations. It designs user-centric platforms enhancing patient engagement and provider workflows in the life sciences sector.
HQ CountryUnited StatesUnited StatesUnited States
HQ City
Dallas, TX
Boston, MA
Rochelle Park, NJ
Deal Date25 Apr 202222 Feb 202221 Dec 2020
Valuationundisclosed$80Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Relevate Health Group acquisitions and their M&A valuation multiples.

Start Free Trial

Relevate Health Group Competitors

Relevate Health Group competitors include listed companies like IQVIA, Veeva, IDEXX Laboratories and Roper Technologies, and private ones like Commure and Doctolib.

Public and private companies comparable to Relevate Health Group
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
IQVIAUnited StatesUnited StatesPublicly listed$16B$3.4B$44B3.4x
VeevaUnited StatesUnited StatesPublicly listed$3.2B$965M$43B10.2x
IDEXX LaboratoriesUnited StatesUnited StatesPublicly listed$4.3B$1.5B$40B8.9x
Roper TechnologiesUnited StatesUnited StatesPublicly listed$7.9B$3.2B$37B5.7x
CommureUnited StatesSan Francisco, CAPrivate$200M-$7B35.0x
DoctolibFranceParisPrivate$400M-$6.4B16.0x

Relevate Health Group Public Comps

Relevate Health Group is still privately-owned, but its public comps include RELX, IQVIA, Thomson Reuters, Veeva, IDEXX Laboratories, Roper Technologies, Experian, GE HealthCare, Publicis Groupe and Omnicom Group.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
RELX$13B$4.9B5.5x5.3x14.4x13.2x
IQVIA$16B$3.4B3.6x3.4x17.2x14.8x
Thomson Reuters$7.5B$3B6.1x5.8x15.3x14.5x
Veeva$3.2B$965M11.1x10.2x36.9x22.4x
IDEXX Laboratories$4.3B$1.5B9.5x8.9x27.1x24.9x
Roper Technologies$7.9B$3.2B6.1x5.7x15.2x14.6x
Experian$8.4B$3B4.5x4.4x12.7x12.1x
GE HealthCare$21B$3.7B1.8x1.8x10.1x10.0x

This data is available for Pro users. Sign up to see all Relevate Health Group competitors and their valuation data.

Start Free Trial

Common questions about Relevate Health Group

When was Relevate Health Group founded?Relevate Health Group was founded in 2015.
Where is Relevate Health Group headquartered?Relevate Health Group is headquartered in Cincinnati, OH, United States.
Is Relevate Health Group publicly listed?No, Relevate Health Group is a private company.
How much funding has Relevate Health Group raised?Relevate Health Group has raised $140M across 3 funding rounds.
What was Relevate Health Group's last funding round?Relevate Health Group's last funding round was a $56M undisclosed-stage round in April 2022.
Which companies are comparable to Relevate Health Group?Companies comparable to Relevate Health Group include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, Commure and Doctolib.
How many companies has Relevate Health Group acquired?Relevate Health Group has acquired 3 companies, including ConneXion 360, Axon Communications and Arteric.
What was the largest acquisition by Relevate Health Group?The $80M acquisition of Axon Communications in February 2022 is the largest acquisition Relevate Health Group has made to date.

See companies similar to Relevate Health Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial